Drug interactions
Insulin neutral human + Linagliptin
Severity: Moderate
Insulin neutral human and Linagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Adding a DPP-4 inhibitor to insulin improves glycemic control but can increase the risk of hypoglycemia. Linagliptin alone rarely causes hypoglycemia, but it does so more often with insulin.
What this interaction means in plain words
Insulin neutral human and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Insulin neutral human belongs to Endocrine; Linagliptin belongs to Endocrine.
Why it happens
Additive glucose lowering: DPP-4 inhibition increases incretin-mediated, glucose-dependent insulin secretion and reduces glucagon.
What to do
Monitor glucose when starting linagliptin and consider reducing the insulin dose to lower hypoglycemia risk.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin neutral human and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Insulin neutral human
Other interactions of Linagliptin
- Alogliptin-pioglitazone + Linagliptin Moderate
- Amlodipine-benazepril + Linagliptin Moderate
- Amobarbital + Linagliptin Moderate
- Apalutamide + Linagliptin Moderate
- Benazepril + Linagliptin Moderate
- Bexarotene + Linagliptin Moderate
Frequently asked questions
Can I take Insulin neutral human with Linagliptin?
MediHelp rates the interaction as moderate. Insulin neutral human and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Adding a DPP-4 inhibitor to insulin improves glycemic control but can increase the risk of hypoglycemia. Linagliptin alone rarely causes hypoglycemia, but it does so more often with insulin.
How serious is the interaction between Insulin neutral human and Linagliptin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose when starting linagliptin and consider reducing the insulin dose to lower hypoglycemia risk.
What other medicines interact with Insulin neutral human?
MediHelp also lists interactions of Insulin neutral human with, for example, Chlorpropamide, Ethanol, Mecasermin. The full list is on the Insulin neutral human page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
